US FDA OKs First Gene Therapy for Sanfilippo Syndrome A
The US FDA has approved the first gene therapy for pediatric patients with Sanfilippo Syndrome Type A, a rare and progressive neurodevelopmental disease.
Sanfilippo Syndrome | 19/09/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy